Study on 10 409 cases of post-marketing safety Danhong injection centralized monitoring of hospital / 中国中药杂志

ABSTRACT

<p><b>OBJECTIVE</b>To study Danhong injection adverse reactions (ADR) incidence, nature and clinical performance, provide the basis for the clinical safety of drugs.</p><p><b>METHOD</b>Multi-center, a large sample of hospitals focused on monitoring method.</p><p><b>RESULT</b>Danhong injection ADR for the rapid onset and ease the quick recovery, the rate was 0. 682% , the newly discovered ADR constipation, sweating, tinnitus, irritability, joint disease, erythema, venous pain, phlebitis, local numbness, pain, weakness, gastrointestinal ulcer bleeding, vasospasm, cyanosis.</p><p><b>CONCLUSION</b>Danhong injection adverse reactions are type A adverse reactions occasionally, centralized monitoring of hospital medicine injection method is to carry out post-marketing safety re-evaluation of appropriate methods.</p>